OAKLAND, CA / ACCESS Newswire / December 10, 2025 / Oakland's psychedelic Church of Ambrosia is trading sacraments for toys ...
A drug launch is one of the most defining events in the pharma and biotech lifecycle. It marks the moment a therapy moves ...
The GDC, established in LTTS’ Mobility segment, will strengthen PALFINGER’s localization roadmap and next-gen digital ...
UPPSALA, SE / ACCESS Newswire / December 10, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) - Senzime AB (publ) today announced the launch of the latest series of innovative features for its next-generation ...
Novartis has struck a $1.7 billion collaboration with Relation Therapeutics to use AI-driven drug discovery and human tissue data to develop novel treatments for atopic diseases including eczema, ...
Pharmaceutical Technology Co., Ltd. (“Biocytogen,” SSE: 688796; HKEX: 02315), a global biotechnology company advancing ...
Modus Therapeutics Holding AB (“Modus”) today announces that the first patient has been dosed in Part 2 of the company’s ongoing Phase IIa clinical study evaluating sevuparin for the treatment of ...
AI continued to dominate the conversation in 2025, but in 2026, healthcare CIOs are shifting gears. After a year of rapid adoption and high expectations surrounding artificial intelligence, 2026 is ...
MRD-negative response rate in four patients; all remain in response through the longest follow up of 5 monthsFavorable ...
Partnering Platform Now Open for RegistrationSAN FRANCISCO--(BUSINESS WIRE)--#biotechshowcase--Biotech Showcase™ returns to ...
Engagement solutions leader acquires C2events in England and Daymakers in the Netherlands, strengthening their ability to ...
Nearly one in four European pharmaceutical companies remains vulnerable to regulatory risks due to inadequate quality systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback